T1D treatment is particularly challenging, since suboptimal, exogenous insulin administration is needed to keep blood glucose within a safe range, avoiding hypo- and hyperglycemic events (low and high blood glucose levels, respectively) [5,6]. Here, INS is linked to type 1 diabetes mellitus.